Semi-Annual Consolidated Statement Of Cash Flows

NANO MRNA Co.,Ltd. - Filing #7725443

Concept As at
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-5,413,178,000 JPY
-2,672,419,000 JPY
Depreciation
26,390,000 JPY
21,248,000 JPY
Impairment losses
141,381,000 JPY
61,821,000 JPY
Foreign exchange losses (gains)
35,072,000 JPY
31,313,000 JPY
Decrease (increase) in trade receivables
-25,755,000 JPY
36,051,000 JPY
Decrease (increase) in inventories
124,075,000 JPY
-126,012,000 JPY
Other, net
-1,156,000 JPY
13,764,000 JPY
Subtotal
-4,964,838,000 JPY
-2,595,448,000 JPY
Income taxes paid
-3,630,000 JPY
-3,226,000 JPY
Net cash provided by (used in) operating activities
-4,927,585,000 JPY
-2,525,557,000 JPY
Cash flows from investing activities
Purchase of securities
-9,034,620,000 JPY
-5,200,000,000 JPY
Purchase of property, plant and equipment
-60,365,000 JPY
-176,351,000 JPY
Purchase of investment securities
-358,767,000 JPY
-112,810,000 JPY
Net cash provided by (used in) investing activities
214,729,000 JPY
-597,249,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-27,000 JPY
Net cash provided by (used in) financing activities
24,065,000 JPY
88,053,000 JPY
Effect of exchange rate change on cash and cash equivalents
-8,323,000 JPY
-29,601,000 JPY
Net increase (decrease) in cash and cash equivalents
-4,697,114,000 JPY
-3,064,353,000 JPY
Cash and cash equivalents
2,688,524,000 JPY
7,385,639,000 JPY
10,449,992,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.